RegCell, Inc.
PrivateLast Round
Grant
Mar 18, 2025
Total Funding Raised
$45.8M
Company Overview
RegCell, Inc. is a biotechnology company that develops first-in-class regulatory T-cell (Treg) therapies for autoimmune diseases and transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RegCell, Inc. Comparables
Compare RegCell, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 86% | |
| Quell Therapeutics | 83% | |
| Mozart Therapeutics | 83% | |
RegCell, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2025 | ||||
| Seed | Mar 18, 2025 |
Key People
Founding team and executive leadership
RegCell, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Seed, Grant |
| UTEC (The University of Tokyo Edge Capital Partners) | Seed |
| Celadon Partners | Seed |
| Mitsubishi UFJ Capital | Seed |
| Kyoto University Innovation Capital | Seed |
| Fast Track Initiative | Seed |
| Osaka University Venture Capital Co., Ltd. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
$37.3M raised in a grant round.
- Mar 18, 2025
Steven B. Kanner joins the Board of Directors.
RegCell, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RegCell, Inc.'s valuation, stock price, and market status.